Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab - Vigipallia

0 avis

Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab

Archive ouverte

Spindeldreher, Sebastian | Maillère, Bernard | Correia, Evelyne | Tenon, Maxime | Karle, Anette | Jarvis, Philip | Kolbinger, Frank

Edité par CCSD -

International audience

Langue: en

Consulter en ligne

Consulter le document

Consulter le document

Consulter le document

Suggestions

Du même auteur

Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab

Archive ouverte | Spindeldreher, Sebastian | CCSD

International audience

T cell epitope mapping of secukinumab and ixekizumab in healthy donors

Archive ouverte | Spindeldreher, Sebastian | CCSD

International audience

State-of-the-art and new options to assess T cell activation by skin sensitizers: Cosmetics Europe Workshop

Archive ouverte | Spindeldreher, Sebastian | CCSD

International audience

Chargement des enrichissements...